Matches in SemOpenAlex for { <https://semopenalex.org/work/W2793353239> ?p ?o ?g. }
- W2793353239 endingPage "9" @default.
- W2793353239 startingPage "1" @default.
- W2793353239 abstract "Epithelial ovarian cancer (EOC) has exhibited marginal improvement in survival rate, despite advances in surgical debulking and chemotherapy regimens. Although the majority of EOC patients achieve a clinical remission after induction therapy, over 80% relapse and succumb to chemoresistant disease. In this regard, it is of paramount importance to elucidate molecular mechanisms and signaling pathways which promote therapy resistance in EOC in order to devise novel and more effective treatment strategies. In this study, we showed that activation of nuclear factor-κB (NF-κB) is significantly higher in therapy-resistant EOC cells compared to chemosensitive counterparts, which was positively associated with resistance to cisplatin, carboplatin, paclitaxel and erlotinib. Bay 11-7082, a highly selective NF-κB inhibitor, reduced cell proliferation, clonogenicity and anoikis resistance in the therapy-resistant EOC cells and induced apoptotic cell death. Moreover, Bay 11-7082 decreased the expression of pro-survival, inflammatory and metastatic genes and synergistically increased anti-proliferative efficacy of cisplatin, carboplatin, paclitaxel and erlotinib. Altogether, these findings suggest that NF-κB is an attractive therapeutic target in EOC to be exploited in translational oncology and Bay 11-7082 is a potential anti-cancer drug to overcome chemoresistance and inhibit proliferation of the EOC cells." @default.
- W2793353239 created "2018-03-29" @default.
- W2793353239 creator A5010856859 @default.
- W2793353239 creator A5015695197 @default.
- W2793353239 creator A5025771771 @default.
- W2793353239 creator A5027416201 @default.
- W2793353239 creator A5029815329 @default.
- W2793353239 creator A5034729928 @default.
- W2793353239 creator A5036536670 @default.
- W2793353239 creator A5040348288 @default.
- W2793353239 creator A5045199940 @default.
- W2793353239 creator A5045344624 @default.
- W2793353239 creator A5050173528 @default.
- W2793353239 creator A5058820289 @default.
- W2793353239 creator A5059116697 @default.
- W2793353239 creator A5060952977 @default.
- W2793353239 creator A5066991751 @default.
- W2793353239 creator A5073010250 @default.
- W2793353239 creator A5075755280 @default.
- W2793353239 creator A5078723044 @default.
- W2793353239 creator A5081126373 @default.
- W2793353239 creator A5085252217 @default.
- W2793353239 creator A5086980259 @default.
- W2793353239 creator A5090828119 @default.
- W2793353239 date "2018-06-01" @default.
- W2793353239 modified "2023-10-01" @default.
- W2793353239 title "Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells" @default.
- W2793353239 cites W1572483109 @default.
- W2793353239 cites W1581923494 @default.
- W2793353239 cites W1601414978 @default.
- W2793353239 cites W1781170077 @default.
- W2793353239 cites W1914677356 @default.
- W2793353239 cites W1966828006 @default.
- W2793353239 cites W1972564258 @default.
- W2793353239 cites W1977647055 @default.
- W2793353239 cites W1980792888 @default.
- W2793353239 cites W1982408819 @default.
- W2793353239 cites W1986856096 @default.
- W2793353239 cites W1988191177 @default.
- W2793353239 cites W1988226967 @default.
- W2793353239 cites W1990367159 @default.
- W2793353239 cites W1996066317 @default.
- W2793353239 cites W1996767494 @default.
- W2793353239 cites W1997559135 @default.
- W2793353239 cites W1997788846 @default.
- W2793353239 cites W2000269194 @default.
- W2793353239 cites W2007279797 @default.
- W2793353239 cites W2033369613 @default.
- W2793353239 cites W2034201098 @default.
- W2793353239 cites W2043118554 @default.
- W2793353239 cites W2048945801 @default.
- W2793353239 cites W2053539848 @default.
- W2793353239 cites W2055019214 @default.
- W2793353239 cites W2055878807 @default.
- W2793353239 cites W2061765285 @default.
- W2793353239 cites W2068854353 @default.
- W2793353239 cites W2077600211 @default.
- W2793353239 cites W2086933609 @default.
- W2793353239 cites W2091823826 @default.
- W2793353239 cites W2092789237 @default.
- W2793353239 cites W2096439168 @default.
- W2793353239 cites W2100999744 @default.
- W2793353239 cites W2101227305 @default.
- W2793353239 cites W2103063473 @default.
- W2793353239 cites W2117692326 @default.
- W2793353239 cites W2117996979 @default.
- W2793353239 cites W2125194042 @default.
- W2793353239 cites W2127281537 @default.
- W2793353239 cites W2129985201 @default.
- W2793353239 cites W2132834292 @default.
- W2793353239 cites W2139836705 @default.
- W2793353239 cites W2143870432 @default.
- W2793353239 cites W2144720355 @default.
- W2793353239 cites W2146426447 @default.
- W2793353239 cites W2148788725 @default.
- W2793353239 cites W2149419747 @default.
- W2793353239 cites W2151414819 @default.
- W2793353239 cites W2157398328 @default.
- W2793353239 cites W2161761916 @default.
- W2793353239 cites W2161786232 @default.
- W2793353239 cites W2166350458 @default.
- W2793353239 cites W2235523093 @default.
- W2793353239 cites W2326647919 @default.
- W2793353239 cites W2335925695 @default.
- W2793353239 cites W2560138732 @default.
- W2793353239 cites W2596065061 @default.
- W2793353239 cites W2605220782 @default.
- W2793353239 cites W2615726315 @default.
- W2793353239 cites W2705345269 @default.
- W2793353239 cites W2754140275 @default.
- W2793353239 cites W4211203170 @default.
- W2793353239 doi "https://doi.org/10.1016/j.biocel.2018.03.015" @default.
- W2793353239 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29567488" @default.
- W2793353239 hasPublicationYear "2018" @default.
- W2793353239 type Work @default.
- W2793353239 sameAs 2793353239 @default.
- W2793353239 citedByCount "31" @default.
- W2793353239 countsByYear W27933532392018 @default.